secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeStance Health Group, Inc. (LFST)
CIK:        0001845257
Form:       8-K
Filed at:   2024-02-28T23:59:59+00:00
Accession:  0000950170-24-021511
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeStance Q4 revenue $280.6M (+22% YoY); net loss $45M; guides FY24 revenue $1.19-$1.24B
--------------------------------------------------------------------------------

- Q4 revenue $280.6M (+22% YoY); full-year revenue $1,055.7M (+23%).
- Q4 net loss $45.0M; full-year net loss $186.3M. Adjusted EBITDA $20.3M (Q4) and $59.0M (FY).
- Added 227 net clinicians in Q4, 1,014 in FY; total clinicians 6,645 (+18% YoY).
- FY2024 guidance: revenue $1.19-$1.24B, Center Margin $345-$365M, Adj. EBITDA $80-$90M, positive free cash flow.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845257/000095017024021511/0000950170-24-021511-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845257/000095017024021511/lfst-20240228.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-021511

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer